Spire Healthcare Group (LON:SPI) Stock Rating Reaffirmed by Peel Hunt – Slater Sentinel
Peel Hunt’s target price indicates a potential upside of 34.55% from the stock’s current price. Royal Bank of Canada reissued an “outperform” rating and set a GBX 149 ($1.95) price objective on shares of Spire Healthcare Group in a research note on Monday, September 9th. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and two have issued a buy rating to the company. Spire Healthcare Group has a 1-year low of GBX 95.25 ($1.24) and a 1-year high of GBX 176 ($2.30).